Bayer | BAYN - Ebitda

Stock Price
38.38
Daily Change
-0.12 -0.31%
Monthly
-1.75%
Yearly
67.01%
Q2 Forecast
37.49

Bayer reported EUR1.97B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Air Liquide EUR 3.82B 205.4M Dec/2025
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 317M 337M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
Arkema EUR 310M 54M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Beiersdorf EUR 984M 147M Jun/2025
Corteva USD 446M 397M Dec/2025
Covestro EUR 242M 24M Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Linde USD 3.38B 30M Sep/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Nutrien USD 1.28B 154M Dec/2025
Philips EUR 738M 9M Sep/2025
PPG Industries USD 596M 163M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
SAP EUR 3.17B 606M Mar/2026
Solvay EUR 169M 63M Dec/2025
UCB EUR 1.6B 570M Dec/2025
Umicore EUR 433M 63M Jun/2025
Vinci EUR 7.83B 1.7B Dec/2025